EFFECT OF SPIRONOLACTONE ON THE RENAL CLEARANCE OF DIGOXIN IN DOGS

被引:0
作者
OBRIEN, MS
SALAMONE, LF
GIBSON, TP
机构
[1] NORTHWESTERN UNIV,NW MEM HOSP,SCH MED,DEPT MED,CHICAGO,IL 60611
[2] NORTHWESTERN UNIV,NW MEM HOSP,SCH MED,NEPHROL & HYPERTENS SECT,CHICAGO,IL 60611
[3] VET ADM LAKESIDE MED CTR,CHICAGO,IL 60611
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:190 / 194
页数:5
相关论文
共 37 条
[1]  
BRIZIOMOLTENI L, 1984, ANN CLIN LAB SCI, V14, P381
[2]  
CASTLE MC, 1973, RES COMMUN CHEM PATH, V6, P601
[3]  
CASTLE MC, 1973, DRUG METAB DISPOS, V1, P590
[4]   MECHANISM OF THE ANTI-MINERALOCORTICOID EFFECTS OF SPIROLACTONES [J].
CORVOL, P ;
CLAIRE, M ;
OBLIN, ME ;
GEERING, K ;
ROSSIER, B .
KIDNEY INTERNATIONAL, 1981, 20 (01) :1-6
[5]   QUINIDINE-DIGOXIN INTERACTION - PHARMACOKINETICS, UNDERLYING MECHANISM AND CLINICAL IMPLICATIONS [J].
DOERING, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (08) :400-404
[6]   DIGOXIN-QUINIDINE INTERACTION - CHANGES IN CANINE TISSUE CONCENTRATION FROM STEADY-STATE WITH QUINIDINE [J].
DOHERTY, JE ;
STRAUB, KD ;
MURPHY, ML ;
SOYZA, ND ;
BISSETT, JK ;
KANE, JJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1980, 45 (06) :1196-1200
[7]   INTERACTIONS OF SPRIONOLACTONE WITH HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYME SYSTEMS [J].
FELLER, DR ;
GERALD, MC .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (08) :1991-&
[8]  
FINOTTI P, 1981, J PHARMACOL EXP THER, V217, P784
[9]   RATE OF CHANGE IN SODIUM AND POTASSIUM EXCRETION AFTER INJECTION OF ALDOSTERONE INTO THE AORTA AND RENAL ARTERY OF THE DOG [J].
GANONG, WF ;
MULROW, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1958, 195 (02) :337-342
[10]  
GIBSON TP, 1980, J LAB CLIN MED, V95, P417